The neuromuscular transmission fade (Wedensky inhibition) induced by L-arginine in neuromuscular preparations from rats

被引:9
作者
Silva, HMV [1 ]
Ambiel, CR [1 ]
Alves-Do-Prado, W [1 ]
机构
[1] Univ Estadual Maringa, Dept Pharmacol, BR-87020900 Maringa, Parana, Brazil
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1999年 / 32卷 / 06期
关键词
skeletal muscle; nitric oxide; tetanic fade; Wedensky inhibition; L-arginine; D-arginine; 3-(4-morpholinyl)-sydonone imine hydrochloride; 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one N-omega-Nitro-L-arginine;
D O I
10.1016/S0306-3623(98)00230-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
L-Arginine (4.7-18.8 mM) and 3-(4-morpholinyl)-sydonone imine hydrochloride (SIN-1; 1.15 mM) induced an increase in tetanic fade caused by indirect stimulation (180-200 Hz) of muscle. However, Wedensky inhibition, different from control, was not observed when the preparations treated with d-tubocurarine were directly stimulated by the same frequency. D-Arginine (9.4 mM) was ineffective in changing R values caused by indirect stimulation (180-200 Hz) of muscle. N-omega-Nitro-L-arginine (73 mM) or 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 10 mu M) did not produce any effect on Wedensky inhibition but did antagonize the tetanic fade induced by L-arginine (9.4 mM). The SIN-1 effect was antagonized by previous administration of ODQ (108 mu M), which alone did not produce any effects on R values. These results indicate that NO acting at the presynaptic level increases the Wedensky inhibition induced by high frequency of stimulation applied on motor nerves, and its effect may be produced through the cGMP-GC pathway. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:705 / 712
页数:8
相关论文
共 50 条
[1]  
ALVESDOPRADO W, 1987, ANESTH ANALG, V66, P492
[2]   Reversal by methylene blue of tetanic fade induced in cats by nitric oxide [J].
Ambiel, CR ;
Alves-Do-Prado, W .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1998, 31 (03) :413-415
[3]   Neuromuscular facilitation and blockade induced by L-arginine and nitric oxide in the rat isolated diaphragm [J].
Ambiel, CR ;
AlvesDoPrado, W .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1997, 28 (05) :789-794
[4]   NITRIC-OXIDE RELEASE IS PRESENT FROM INCUBATED SKELETAL-MUSCLE PREPARATIONS [J].
BALON, TW ;
NADLER, JL .
JOURNAL OF APPLIED PHYSIOLOGY, 1994, 77 (06) :2519-2521
[5]   PREJUNCTIONAL ACTIONS OF SOME NON-DEPOLARIZING BLOCKING-DRUGS [J].
BLABER, LC .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (01) :109-116
[6]   NITRIC OXIDE-DEPENDENT LONG-TERM POTENTIATION IS BLOCKED BY A SPECIFIC INHIBITOR OF SOLUBLE GUANYLYL CYCLASE [J].
BOULTON, CL ;
SOUTHAM, E ;
GARTHWAITE, J .
NEUROSCIENCE, 1995, 69 (03) :699-703
[7]   TETANIC FADE DURING PARTIAL TRANSMISSION FAILURE PRODUCED BY NON-DEPOLARIZING NEUROMUSCULAR BLOCKING-DRUGS IN CAT [J].
BOWMAN, WC ;
WEBB, SN .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1976, 3 (06) :545-555
[8]  
BOWMAN WC, 1980, ANESTH ANALG, V59, P935
[9]  
Brunner F, 1996, J PHARMACOL EXP THER, V277, P48
[10]  
BULBRING E, 1946, BRIT J PHARM CHEMOTH, V1, P38